Upcoming Webinars
-
Ripped from the Headlines: Hot Topics in Life Sciences 2026
The life sciences industry is constantly changing, and equally dynamic are the challenges industry participants encounter. Join Medmarc's Risk Managers to discuss these changes from 2026.
Register for Ripped from the Headlines: Hot Topics in Life Sciences 2026 Read More about Ripped from the Headlines: Hot Topics in Life Sciences 2026 -
What’s Next in Products Liability: The 2026 Life Sciences Update
Join Andy Hall as he gives an update on the claims and legal environment for life science companies.
Register for What’s Next in Products Liability: The 2026 Life Sciences Update Read More about What’s Next in Products Liability: The 2026 Life Sciences Update
Past Webinars
-
The Potential Life Sciences Implications of the Election
The medtech industry has significantly changed during the Trump administration’s last four years. FDA processes are streamlined, the medical device excise tax repealed, and the Senate is in the...
Read More about The Potential Life Sciences Implications of the Election -
How to Write Effective and Compliant Standard Operating Procedures (SOPs)
In this session, presenter, Joy McElroy from McElroy Training and Consultancy, will discuss the benefits of good technical writing, how to write effective and compliant SOPs using the correct...
Read More about How to Write Effective and Compliant Standard Operating Procedures (SOPs) -
Clinical Trials in The Era of COVID-19
This session presenters, Dianne Bourque and Benjamin Zegarelli from Mintz, will explore the widespread disruptions the crisis is posing to clinical trials for life sciences companies and to research...
Read More about Clinical Trials in The Era of COVID-19 -
Mitigating Product Liability Risk in the Era of COVID-19
The following topics will be covered in this webinar: Outlining potential product liability risk involving COVID (defect claims involving marketing/advertising, warranties, and warnings) Tips on...
Read More about Mitigating Product Liability Risk in the Era of COVID-19
